Tracy Cunningham

Technik-/Wissenschafts-/F&E-Leiter bei AMRYT PHARMA PLC

Health Technology

Consumer Services

Government

Aktive Positionen von Tracy Cunningham

Unternehmen	Position	Beginn	Ende
AMRYT PHARMA PLC	Technik-/Wissenschafts-/F&E-Leiter	01.04.2020	-
Health Research Board	Direktor/Vorstandsmitglied	-	-

Unternehmen	Position	Beginn	Ende
ASTRAZENECA PLC	Corporate Officer/Principal	-	-
Amryt Pharma Holdings Ltd. Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom.	Technik-/Wissenschafts-/F&E-Leiter	27.06.2022	-
	Corporate Officer/Principal	01.04.2020	27.06.2022

Royal College of Surgeons

Undergraduate Degree

International

Vereinigtes Königreich	4
Irland	3

Operativ

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	2
Undergraduate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
ASTRAZENECA PLC	Health Technology

Private Unternehmen	3
Health Research Board	Government
Amryt Pharma Holdings Ltd. Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom.	Health Technology
Amryt Pharma Plc Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland.	Health Technology